Get Premium to unlock powerful stock data
Illumina Inc logo

Illumina Inc

$ 258.06 +14.49 (+5.95%) 10:08 PM EST
P/E:
56.11
P/B:
3.72
Market Cap:
$ 40.54B
Enterprise V:
$ 39.46B
Volume:
1.21M
Avg Vol (2M):
1.03M
Also Trade In:
Volume:
1.21M
Market Cap $:
40.54B
PE Ratio:
56.11
Avg Vol (2-Month):
1.03M
Enterprise Value $:
39.46B
PB Ratio:
3.72
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Description
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (76% of 2020 sales). Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 16% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.
Name Current Vs Industry Vs History
Cash-To-Debt 0.54
Equity-to-Asset 0.71
Debt-to-Equity 0.24
Debt-to-EBITDA 2.19
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.36
Distress
Grey
Safe
Beneish M-Score -1.39
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 75.81
9-Day RSI 55.63
14-Day RSI 46.32
6-1 Month Momentum % -19.54
12-1 Month Momentum % -27.25

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.85
Quick Ratio 1.54
Cash Ratio 0.95
Days Inventory 102.61
Days Sales Outstanding 45.83
Days Payable 62.79

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.2

Financials (Next Earnings Date:2022-08-05 Est.)

ILMN's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ILMN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 4,656
EPS (TTM) ($) 4.6
Beta 0.9
Volatility % 33.16
14-Day RSI 46.32
14-Day ATR ($) 12.329475
20-Day SMA ($) 249.2375
12-1 Month Momentum % -27.25
52-Week Range ($) 208.35 - 526
Shares Outstanding (Mil) 157.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Illumina Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More